Taro Provides Results for September 30, 2016

Go back to Taro Provides Results for September 30, 2016

Taro Pharma (TARO) Reports Q2 EPS of $3.00

November 8, 2016 5:33 PM EST

Taro Pharma (NYSE: TARO) reported Q2 EPS of $3.00, versus $3.11 reported last year. Revenue for the quarter came in at $228.8 million, versus $212.06 million reported last year.

For earnings history and earnings-related data on Taro Pharma (TARO) click here.

... More